JP2006519189A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519189A5
JP2006519189A5 JP2006501737A JP2006501737A JP2006519189A5 JP 2006519189 A5 JP2006519189 A5 JP 2006519189A5 JP 2006501737 A JP2006501737 A JP 2006501737A JP 2006501737 A JP2006501737 A JP 2006501737A JP 2006519189 A5 JP2006519189 A5 JP 2006519189A5
Authority
JP
Japan
Prior art keywords
hsgk1
gene
hsgk3
aliquots
accession
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006501737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006519189A (ja
Filing date
Publication date
Priority claimed from DE10305212A external-priority patent/DE10305212A1/de
Application filed filed Critical
Publication of JP2006519189A publication Critical patent/JP2006519189A/ja
Publication of JP2006519189A5 publication Critical patent/JP2006519189A5/ja
Pending legal-status Critical Current

Links

JP2006501737A 2003-02-07 2004-02-05 白内障および緑内障を診断および治療するための、ｓｇｋ遺伝子ファミリーの使用 Pending JP2006519189A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10305212A DE10305212A1 (de) 2003-02-07 2003-02-07 Verwendung der sgk-Genfamilie zur Diagnose und zur Therapie von Katarakt und Glaukom
PCT/EP2004/001048 WO2004069258A2 (de) 2003-02-07 2004-02-05 Verwendung der sgk-genfamilie zur diagnose und zur therapie von katarakt und glaukom

Publications (2)

Publication Number Publication Date
JP2006519189A JP2006519189A (ja) 2006-08-24
JP2006519189A5 true JP2006519189A5 (enExample) 2007-03-08

Family

ID=32730900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006501737A Pending JP2006519189A (ja) 2003-02-07 2004-02-05 白内障および緑内障を診断および治療するための、ｓｇｋ遺伝子ファミリーの使用

Country Status (13)

Country Link
EP (1) EP1663246A2 (enExample)
JP (1) JP2006519189A (enExample)
KR (1) KR20050114214A (enExample)
CN (1) CN1771039A (enExample)
AU (1) AU2004210416A1 (enExample)
BR (1) BRPI0407300A (enExample)
CA (1) CA2514703A1 (enExample)
DE (1) DE10305212A1 (enExample)
MX (1) MXPA05008394A (enExample)
PL (1) PL378399A1 (enExample)
RU (1) RU2005127808A (enExample)
WO (1) WO2004069258A2 (enExample)
ZA (1) ZA200506280B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070191326A1 (en) * 2004-03-11 2007-08-16 Florian Lang Methods for modulating glutamate receptors for treating neuropsychiatric disorders comprising the use of modulators of serum and glucocorticoid inducible kinases
US20070203085A1 (en) * 2004-03-11 2007-08-30 Florian Lang Methods For Interfering With Fibrosis
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
US20060293378A1 (en) * 2005-06-28 2006-12-28 Mcintire Gregory Method of lowering intraocular pressure
WO2007037560A1 (ja) * 2005-09-30 2007-04-05 Link Genomics, Inc. Ｓｇｋ２遺伝子の治療的又は診断的用途
AU2006318550A1 (en) * 2005-11-22 2007-05-31 Mcgill University Intraocular pressure-regulated early genes and uses thereof
WO2008079980A1 (en) * 2006-12-22 2008-07-03 Alcon Research, Ltd. Inhibitors of protein kinase c-delta for the treatment of glaucoma
DE102008029072A1 (de) * 2008-06-10 2009-12-17 Lang, Florian, Prof. Dr.med. Sgk3 als therapeutisches und diagnostisches Target für Alterserkrankungen
EP2667885B1 (en) * 2011-01-25 2018-08-08 Monell Chemical Senses Center Compositions and methods for providing or modulating sweet taste and methods of screening therefor
KR102357260B1 (ko) * 2020-12-10 2022-02-08 주식회사 레피겐엠디 마이크로rna를 이용한 당뇨병성 신경병증의 예측 및 진단 방법 및 이를 위한 키트
CN119303113A (zh) * 2024-09-03 2025-01-14 河北大学附属医院 Nedd4l基因在制备治疗血管内皮细胞增生性相关疾病药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69535673D1 (de) * 1994-08-30 2008-02-07 Univ Dundee Mittel zur induktion von apoptosis und zur therapieanwendung
CA2222562A1 (en) * 1995-06-07 1996-12-19 Jeffrey N. Miner Method for screening for receptor agonists and antagonists
US5925523A (en) * 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
DE19708173A1 (de) * 1997-02-28 1998-09-03 Dade Behring Marburg Gmbh Zellvolumenregulierte humane Kinase h-sgk
AU3991499A (en) * 1998-05-15 1999-12-06 Joslin Diabetes Center Independent regulation of basal and insulin-stimulated glucose transport
WO2000035946A1 (en) * 1998-12-14 2000-06-22 The University Of Dundee Methods
US6399655B1 (en) * 1998-12-22 2002-06-04 Johns Hopkins University, School Of Medicine Method for the prophylactic treatment of cataracts
DE19917990A1 (de) * 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
AU5840300A (en) * 1999-07-14 2001-01-30 University Of Lausanne Glutx polypeptide family and nucleic acids encoding same
US6416759B1 (en) * 1999-09-30 2002-07-09 The Regents Of The University Of California Antiproliferative Sgk reagents and methods
US20030236246A1 (en) * 2002-04-30 2003-12-25 Brazzell Romulus Kimbro Method for decreasing capillary permeability in the retina
DE10225844A1 (de) * 2002-06-04 2003-12-18 Lang Florian sgk und nedd als diagnostische und therapeutische targets

Similar Documents

Publication Publication Date Title
JP6448149B2 (ja) 肝線維症に関連する遺伝的多型、その検出方法および使用
McCooke et al. A novel mutation causing nephronophthisis in the Lewis polycystic kidney rat localises to a conserved RCC1 domain in Nek8
Riazuddin et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p
Zhao et al. Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs
Hubner et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease
CN102177436B (zh) 鉴定疾病风险因子的方法
Esteves et al. Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia
Rendtorff et al. A novel missense mutation in ACTG1 causes dominant deafness in a Norwegian DFNA20/26 family, but ACTG1 mutations are not frequent among families with hereditary hearing impairment
Runcie et al. Social environment influences the relationship between genotype and gene expression in wild baboons
Guan et al. Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans
Mouton et al. MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients
ES2373044T3 (es) Procedimientos y composiciones para predecir la respuesta a warfarina.
Gnaien et al. A gain-of-function mutation in zinc cluster transcription factor Rob1 drives Candida albicans adaptive growth in the cystic fibrosis lung environment
Kato et al. Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese
Cunnington et al. STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression
RU2005127808A (ru) Применение генов семейства sgk для диагностики и терапии катаракты и глаукомы
Shaikh et al. A new locus for nonsyndromic deafness DFNB51 maps to chromosome 11p13-p12
CN103667301B (zh) 冠心病相关基因及其体外检测的试剂、制剂或试剂盒、应用
US10704098B2 (en) Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis
Goldsmith et al. The sound of silence: autosomal recessive congenital ichthyosis caused by a synonymous mutation in ABCA 12
Zennaro et al. Overview of aldosterone-related genetic syndromes and recent advances
Lehman et al. Evaluation of tight junction protein 1 encoding zona occludens 1 as a candidate gene for albuminuria in a Mexican American population
US20060100132A1 (en) Method for diagnosing inflammatory bowel disease
US20130274132A1 (en) Genetic Modifiers of Cystic Fibrosis
Shchagina et al. Genetic Landscape of SH3TC2 variants in Russian patients with Charcot–Marie–Tooth disease